178 related articles for article (PubMed ID: 20683030)
1. Estrogen receptors alpha and beta immunohistochemical expression: clinicopathological correlations in pituitary adenomas.
Manoranjan B; Salehi F; Scheithauer BW; Rotondo F; Kovacs K; Cusimano MD
Anticancer Res; 2010 Jul; 30(7):2897-904. PubMed ID: 20683030
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenoma: a DNA flow cytometric study of 192 clinicopathologically characterized tumors.
Gaffey TA; Scheithauer BW; Leech RW; Blick K; Kovacs K; Horvath E; Weaver AL; Lloyd RV; Ebersold M; Laws ER; DeBault LE
Clin Neuropathol; 2005; 24(2):56-63. PubMed ID: 15803804
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
[TBL] [Abstract][Full Text] [Related]
6. Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors.
Shupnik MA; Pitt LK; Soh AY; Anderson A; Lopes MB; Laws ER
J Clin Endocrinol Metab; 1998 Nov; 83(11):3965-72. PubMed ID: 9814476
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions.
Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H
Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of pituitary tumor transforming gene (PTTG) in pituitary adenomas: a correlative study of tumor subtypes.
Salehi F; Kovacs K; Scheithauer BW; Cantelmi D; Horvath E; Lloyd RV; Cusimano M
Int J Surg Pathol; 2010 Feb; 18(1):5-13. PubMed ID: 20106827
[TBL] [Abstract][Full Text] [Related]
10. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen receptor alpha and beta in female rat pituitary cells: an immunochemical study.
González M; Reyes R; Damas C; Alonso R; Bello AR
Gen Comp Endocrinol; 2008 Feb; 155(3):857-68. PubMed ID: 18067893
[TBL] [Abstract][Full Text] [Related]
12. In nonfunctional pituitary adenomas, estrogen receptors and slug contribute to development of invasiveness.
Zhou W; Song Y; Xu H; Zhou K; Zhang W; Chen J; Qin M; Yi H; Gustafsson JA; Yang H; Fan X
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1237-45. PubMed ID: 21632819
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen receptor beta expression in pleomorphic adenomas of the parotid gland.
Wong MH; Dobbins TA; Tseung J; Tran N; Lee CS; O'Brien CJ; Clark J; Rose BR
J Clin Pathol; 2009 Sep; 62(9):789-93. PubMed ID: 19734474
[TBL] [Abstract][Full Text] [Related]
18. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical studies on human pituitary gland and adenomas.
Kasper M; Kasper M; Kern F; Heitz PU; Gudat F
J Hirnforsch; 1991; 32(6):725-34. PubMed ID: 1821419
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas].
Sanno N; Teramoto A; Inada K; Osamura Y
No To Shinkei; 1992 Aug; 44(8):745-53. PubMed ID: 1419353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
